SLC18A1

Chromaffin granule amine transporter · P54219 · SLC18A1 on Sugi Atlas →

756 patent compounds predicted against SLC18A1, 695 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
Reserpine Reserpine (SCHEMBL2589) 1.00 1/20
Isoreserpine Isoreserpine (SCHEMBL731599) 1.00 1/20
Reserpine Reserpine (SCHEMBL1172973) 1.00 1/20
Reserpine Reserpine (SCHEMBL4562878) 1.00 1/20
Reserpine Reserpine (SCHEMBL5372164) 1.00 1/20
Reserpine Reserpine (SCHEMBL5372168) 1.00 1/20
Reserpine Reserpine (SCHEMBL8262666) 1.00 1/20
Reserpine Reserpine (SCHEMBL12732449) 1.00 1/20
Reserpine Reserpine (SCHEMBL14379427) 1.00 1/20
Reserpine Reserpine (SCHEMBL15385127) 1.00 1/20
Reserpine Reserpine (SCHEMBL20402680) 1.00 1/20
Reserpine Reserpine (SCHEMBL22002247) 1.00 1/20
Reserpine Reserpine (SCHEMBL241313) 0.99 1/20
Reserpine Reserpine (SCHEMBL1579009) 0.99 1/20
Reserpine Reserpine (SCHEMBL2699112) 0.99 1/20
Reserpine Reserpine (SCHEMBL2770274) 0.99 1/20
Reserpine Reserpine (SCHEMBL4773721) 0.99 1/20
Reserpine Reserpine (SCHEMBL6164539) 0.99 1/20
Reserpine Reserpine (SCHEMBL7214249) 0.99 1/20
Reserpine Reserpine (SCHEMBL8743761) 0.99 1/20

Clinical trials — most relevant to SLC18A1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Weight Loss Study: Genetics and Response to Naltrexone/Bupropion PHASE4RECRUITING
Pharmacogenetic Treatment With Anti-Glutaminergic Agents for Comorbid PTSD & AUD PHASE3COMPLETED
New Treatment for Alcohol and Nicotine Dependence PHASE2/PHASE3COMPLETED
The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room PHASE2/PHASE3COMPLETED
Xenazine in Late Dyskinetic Syndrome With Neuroleptics PHASE3COMPLETED
18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism PHASE2RECRUITING
18F-FDOPA PET in Neuroendocrine Tumours nanNO_LONGER_AVAILABLE
DaTSCAN Brain Scintigraphy and Psychotropic Treatments: Influence on Radiotracer Binding nanCOMPLETED
TRANSEURO Open Label Transplant Study in Parkinson's Disease nanCOMPLETED
Investigation of Serotonin Neurotransmission in MDMA Users Using Combinated Dexfenfluramine Challenge and PET Imaging nanCOMPLETED
Insulin Detemir in Obesity Management nanACTIVE_NOT_RECRUITING
POTS NET mRNA Functional Correlation With NET Activity nanACTIVE_NOT_RECRUITING
I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers nanCOMPLETED
Stem Cell Study of Genetics and Drug Addiction nanCOMPLETED
Autonomic Function in Patients With COPD nanCOMPLETED
PET Whole Body Distribution Studies Using [11C]CUMI nanCOMPLETED
Genetic Variants Associated With Adolescent Suicide Attempts nanCOMPLETED
Study of Chediak-Higashi Syndrome nanRECRUITING
Oral Melatonin Versus Oral Pregabalin on Postoperative Pain and Anxiety Following Spine Surgery nanRECRUITING
Caffeine Efficacy in ADCY5-related Dyskinesia nanUNKNOWN
Blood Sampling for Neurochemical and Genetic Testing nanCOMPLETED
Therapeutic Outcomes of Selective Serotonin Reuptake Inhibitors and Phosphodiesterase-5 Inhibitors Combination Therapy Versus Monotherapy nanNOT_YET_RECRUITING
Neuropathological Changes of the Intestinal Wall in Patients With Bowel Evacuation Disorders nanRECRUITING
PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility nanUNKNOWN
The Role of Arachidonic Acid Metabolites, From Patients With Metabolic Syndrome nanUNKNOWN
Role of Neurotransmission and Functional CNS Networks in Spasmodic Dysphonia nanCOMPLETED
Molecular Epidemiology of Parkinson's Disease nanCOMPLETED
Childhood Adversity, Genetic Polymorphisms and Stress in First Onset Major Depression nanCOMPLETED
Can Acupuncture Treat Post-stroke Depression? nanCOMPLETED
Investigations of the Pathophysiology of Gilles de la Tourette Syndrome. Part 1: Simultaneous PET and 3T MRI nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC18A1 binder may also engage these)

ProteinNameSimilarity
Q01818 1.000 Q01818 →
Q8R090 0.998 Q8R090 →
Q27963 0.989 Q27963 →
Q8BRU6 0.980 Q8BRU6 →
Q01827 0.977 Q01827 →
SLC18A2 Synaptic vesicular amine transporter 0.972 landscape →
Q8NHS3 0.964 Q8NHS3 →
F1NCD6 0.962 F1NCD6 →
Q58CV5 0.961 Q58CV5 →
B0JZE1 0.960 B0JZE1 →
Q9WU81 0.959 Q9WU81 →
Q8BH31 0.958 Q8BH31 →
Q8TED4 0.956 Q8TED4 →
Q9DA75 0.956 Q9DA75 →
Q9JHI9 0.955 Q9JHI9 →
Q7SY29 0.955 Q7SY29 →
Q80T22 0.954 Q80T22 →
Q5TF39 0.952 Q5TF39 →
Q923U9 0.952 Q923U9 →
Q8NA29 0.952 Q8NA29 →
Q6DEJ6 0.952 Q6DEJ6 →
Q8R070 0.951 Q8R070 →
Q5ZIT9 0.950 Q5ZIT9 →
Q0IHM1 0.950 Q0IHM1 →
SLC40A1 Ferroportin 0.949 landscape →
Q17QZ3 0.949 Q17QZ3 →
E2RFJ3 0.947 E2RFJ3 →
Q1JP63 0.947 Q1JP63 →
Q9DC37 0.947 Q9DC37 →
Q9I9R3 0.947 Q9I9R3 →